Tjoapack’s Advanced Packaging Expansion Aims to Meet Rising Demand

Contract packaging organization, Tjoapack, announced in December 2025 that it is expanding its packaging services and operational footprint in the United States. A new 170,000-sq.-ft. facility will be built next to the company’s existing site in Clinton, Tenn. The new facility, scheduled to be completed in early 2027, will include a good manufacturing practice suite with packaging, labeling, cold chain, and ambient storage capabilities.

The expansion will support high-speed packaging lines for a variety of dosage forms, such as solid dosage bottles and blister packs, vials and autoinjectors for injectable products, and secondary packaging.

“This expansion marks a major step in our strategic goal to enhance our presence in the United States. As a crucial market with considerable growth opportunities, it allows us to serve our existing clients more effectively and attract new ones.” said Dexter Tjoa, CEO of Tjoapack, in a press release (1). “We’ve invested heavily in automating our core processes, not only within packaging lines but throughout our cross-company workflows with customers and material vendors. This allows us to reduce human error and enhance accuracy, speed, and flexibility, which ultimately benefits our clients.”

What other expansions has the company invested in?

In June of 2025, Tjoapack announced it was expanding cold chain storage services in both the US and The Netherlands for injectables and biologics (2). The company’s Etten-Leur site in The Netherlands added 84 pallet spaces, and its Clinton, Tenn. facility completed installation of two advanced packaging lines. The site added a high-speed, full automated vial packaging line with an annual processing capability of 20 million vials. Cold storage capacity was also expanded at the site with a total of 160 good manufacturing practice-compliant pallet spaces controlled at 2–8 °C.

What will Tjoapack be showcasing at Pharmapack Europe 2026?

Tjoapack with be showcasing its packaging solutions at the 2026 Pharmapack Europe event in Paris on January 21–22 at Paris Expo Porte de Versailles. The team will be at Stand 4D118 to talk about the company’s capabilities in oral solid dosage packaging, vials and prefilled syringes, primary packaging, secondary packaging, biotech packaging, and unit dose packaging.

What are some recent innovations in pharma packaging?

Peter Belden, president of Tjoapack US, sat down with Pharmaceutical Technology® in March 2025 to discuss innovations in bio/pharmaceutical packaging, such as those that have resulted from the demand for temperature-sensitive therapies and customized packaging configurations (3).

“We've been investing heavily in expanding our cold chain capabilities, in expanding our capability and capacity to package unique configuration for injectable products, whether that is a product that comes to us in a syringe format, a vial format, or an auto injector format,” Belden said in the interview. “[We have] the ability to either automate or semi-automate, label, and then finish [to] pack those products while maintaining tight control of time [and] temperature to allow for packaging, and then getting those materials and finished goods back into cold storage. [We also serve] as a potential logistics hub for several of our clients to manage the supply complexity, then shipping those time- and temperature-sensitive medicines to the many markets around the world that our client base is serving.”

Sustainability has also been impacting the choices made for packaging materials, as companies work to meet environmental standards. Maija Pohjakallio, vice-president, Climate and Circular Economy, Metsä Group, spoke with PharmTech before her presentation at CPHI Frankfurt 2025 in October about fiber-based packaging and how it can help pharmaceutical companies meet their sustainability goals (4).

“By definition, fiber-based packaging means packaging that is made of paper or paper board. Paper and paper board is made from pulp, and the typical raw material for pulp is wood,” Pohjakallio explains.

According to Pohjakallio, the wood must be sourced from sustainable sources. For example, all the wood procured by Metsä Group and Metsä Board comes from either certified forests or forests that meet the requirements of controlled origin. The procured wood is also utilized in a sustainable way, she explains. For instance, logs from the thickest part of the trees are utilized for making mechanical wood products, and wood from the thinner parts of the trees that don't qualify for timber and construction elements are used for making pulp.

References

1. Tjoapack. Tjoapack Announces Major US Expansion to Improve its Packaging and Logistics Capabilities. Press Release. Dec. 5, 2025. https://www.tjoapack.com/news-events/tjoapack-announces-major-us-expansion-to-improve-its-packaging-and-logistics-capabilities
2. Tjoapack. Tjoapack Continues to Expand Its Global Infrastructure with Strategic Investments in Injectable Packaging and Cold Chain Capabilities. Press Release. June 5, 2025.
3. Haigney, S. DCAT Week 2025: Packaging Innovations. PharmTech.com. March 17, 2025. https://www.pharmtech.com/view/dcat-week-2025-packaging-innovations
4. Haigney, S. CPHI Frankfurt 2025: Fiber-Based Packaging for Sustainability. PharmTech.com. Oct. 27, 2025. https://www.pharmtech.com/view/cphi-frankfurt-2025-fiber-based-packaging-for-sustainability